The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...
A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...
By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...
Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will ...
Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...
News Medical on MSN1d
AI-designed drug shows promise for inflammatory bowel diseaseInsilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announces positive results from two Phase I studies in ...
Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash., Jan. 08, ...
Among the hundreds of thousands of chemical compounds produced by plants, some may hold the key to treating human ailments ...
DPA International on MSN1d
Novo Nordisk expands drug collaboration with Valo HealthDenmark's Novo Nordisk on Wednesday announced an expansion of its collaboration with Valo Health to discover and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback